Sherbrooke Park Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,433	Closed	-$475K	–	786
2024 Q4	$475K	Sell	4,433 -1,260	-22%	-$135K	0.15%	233
2024 Q3	$570K	Buy	+5,693	New	+$570K	0.13%	255